Jiang, W., Chen, JY. et al. (2020). Intravenous delivery of enzalutamide based on high drug loading multifunctional graphene oxide nanoparticles for castration-resistant prostate cancer therapy. Journal of Nanobiotechnology. 18(1):50. doi: 10.1186/s12951-020-00607-4.

Jiang, W., Gao, Y. et al. (2019). Codelivery of miR-4638–5p and Docetaxel Based on Redox-Sensitive Polypeptide Micelles as an Improved Strategy for the Treatment of Castration-Resistant Prostate Cancer. Molecular pharmaceutics. 1, 437-447. doi: 10.1021/acs.molpharmaceut.8b01074

Qiang, L., Cai, Z., Jiang, W. et al.  (2019). A novel macrophage-mediated biomimetic delivery system with NIR-triggered release for prostate cancer therapy. Journal of Nanobiotechnology. 17, 83-97. doi:10.1186/s12951-019-0513-z

Chen, N., Di, PW., Ning SQ., Jiang, W. et al. (2018) Modified rivaroxaban microparticles for solid state properties improvement based on drug-protein/polymer supramolecular interactions. Powder technology. 344, 819-829. doi: 10.1016/j.powtec.2018.12.085

2016: Bachelor of Pharmaceutical Engineering, East China University of Science and Technology, Shanghai, China    

2019: Master of Pharmaceutical Engineering, East China University of Science and Technology, Shanghai, China           

• First Academic Scholarship in East China University of Science and Technology, 2017/2018/2019
• Bronze Medal of Chinese Students’ Innovation and entrepreneurship competition, 2017
• Silver Medal of Shanghai Students’ Innovation and entrepreneurship competition, 2017
• Bronze Medal of Chinese National Pharmaceutical Engineering Design Competition, 2016